NAVIGATOR Shows Valsartan Delayed Progression To Type 2 Diabetes In At-Risk Cardiovascular Patients With Impaired Glucose Tolerance

Links shared publicly online about this topic.

  • 1,289
    total visits

NAVIGATOR Shows Valsartan Delayed Progression To Type 2 Diabetes In At-Risk Cardiovascular Patients With Impaired Glucose Tolerance

mnt.to

Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease

View full resource at mnt.to

Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication, Diabetes, Type 2 Diabetes, Disease and Condition, Diovan

  • Share

Most Recently Shared on March 25, 2010 at 2:24 pm By:

HeartsHealth Heart Health

MedicalNewsToday: NAVIGATOR Shows Valsartan Delayed Progression To Type 2 Diabetes In: http://bit.ly/cykg2Q Full http://bit.ly/dparJk

2 years ago...

NAVIGATOR Shows Valsartan Delayed Progression To Type 2 Diabetes In At-Risk Cardiovascular Patients With Impaired Glucose Tolerance

medicalnewstoday.com — “Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular diseaseView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 25, 2010 at 2:28 pm By:

monajauharRD Mona Jauhar Health Professional

MedicalNewsToday: NAVIGATOR Shows Valsartan Delayed Progression To Type 2 Diabetes In At-Risk Cardiovascular Patie... http://mnt.to/f/3zrF

2 years ago...

Advertisement